Marinus Pharmaceuticals Inc (MRNS)
0.2571
+0.02
(+8.03%)
USD |
NASDAQ |
Dec 24, 13:00
0.2571
0.00 (0.00%)
After-Hours: 13:35
Marinus Pharmaceuticals Total Liabilities (Quarterly): 130.36M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| AbbVie Inc | 137.35B |
| Viking Therapeutics Inc | 26.44M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.62M |
| Shareholders Equity (Quarterly) | -66.74M |
| Debt to Equity Ratio | -0.8269 |
| Current Ratio | 1.664 |
| Net Debt Paydown Yield | 3.46% |